DDrare
Disease
Drug
Target Gene/Pathway
Contact
JA
Drug
Description in Trials
/
DrugBank
/
KEGG DRUG
Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Other
Search results
10
50
100
ALL
descriptions per page:
Showing 1 to 8 of 8 descriptions
Filter by
Reset
|
No.
Drug (Description in trials)
DrugBank
KEGG DRUG
KEGG GENES
KEGG PATHWAY
Disease ID
1
Baricitinib
[1]
Baricitinib
Baricitinib
(
Baricitinib
)
[1]
Baricitinib
Baricitinib
(
Baricitinib
, OTHER
BARICITINIB
)
💬
1.
Baricitinib
×
Name
Other Names
Baricitinib
Baricitinib (JAN/USAN/INN)
Olumiant (TN)
OTHER BARICITINIB
[2]
JAK1
JAK1
,
JAK2
💬
1.
Baricitinib
×
Name
Full Name
JAK1
Janus kinase 1
JAK2
Janus kinase 2
[35]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
[35]
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
[13]
2
2
,
41
,
46
,
49
,
50
,
51
,
53
,
93
,
107
,
162
,
265
,
269
,
325
💬
1.
Baricitinib
×
Disease ID
Name
2
Amyotrophic lateral sclerosis
41
Giant cell arteritis
46
Malignant rheumatoid arthritis
49
Systemic lupus erythematosus
50
Dermatomyositis
51
Scleroderma
53
Sjogren syndrome
93
Primary biliary cholangitis
107
Juvenile idiopathic arthritis
162
Pemphigoid
265
Lipodystrophy
269
Pyogenic arthritis
325
Hereditary autoinflammatory syndrome
2
Baricitinib
2 MG
[1]
Baricitinib
Baricitinib
(
Baricitinib
)
[1]
Baricitinib
Baricitinib
(
Baricitinib
, OTHER
BARICITINIB
)
💬
2.
Baricitinib
2 MG
×
Name
Other Names
Baricitinib
Baricitinib (JAN/USAN/INN)
Olumiant (TN)
OTHER BARICITINIB
[2]
JAK1
JAK1
,
JAK2
💬
2.
Baricitinib
2 MG
×
Name
Full Name
JAK1
Janus kinase 1
JAK2
Janus kinase 2
[35]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
[35]
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
[2]
46
46
,
53
💬
2.
Baricitinib
2 MG
×
Disease ID
Name
46
Malignant rheumatoid arthritis
53
Sjogren syndrome
3
Baricitinib
2 MG [Olumiant]
[1]
Baricitinib
Baricitinib
(
Baricitinib
)
[1]
Baricitinib
Baricitinib
(
Baricitinib
, OTHER
BARICITINIB
)
💬
3.
Baricitinib
2 MG [Olumiant]
×
Name
Other Names
Baricitinib
Baricitinib (JAN/USAN/INN)
Olumiant (TN)
OTHER BARICITINIB
[2]
JAK1
JAK1
,
JAK2
💬
3.
Baricitinib
2 MG [Olumiant]
×
Name
Full Name
JAK1
Janus kinase 1
JAK2
Janus kinase 2
[35]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
[35]
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
[1]
162
162
💬
3.
Baricitinib
2 MG [Olumiant]
×
Disease ID
Name
162
Pemphigoid
4
Baricitinib
4 MG
[1]
Baricitinib
Baricitinib
(
Baricitinib
)
[1]
Baricitinib
Baricitinib
(
Baricitinib
, OTHER
BARICITINIB
)
💬
4.
Baricitinib
4 MG
×
Name
Other Names
Baricitinib
Baricitinib (JAN/USAN/INN)
Olumiant (TN)
OTHER BARICITINIB
[2]
JAK1
JAK1
,
JAK2
💬
4.
Baricitinib
4 MG
×
Name
Full Name
JAK1
Janus kinase 1
JAK2
Janus kinase 2
[35]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
[35]
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
[1]
46
46
💬
4.
Baricitinib
4 MG
×
Disease ID
Name
46
Malignant rheumatoid arthritis
5
Baricitinib
treatment
[1]
Baricitinib
Baricitinib
(
Baricitinib
)
[1]
Baricitinib
Baricitinib
(
Baricitinib
, OTHER
BARICITINIB
)
💬
5.
Baricitinib
treatment
×
Name
Other Names
Baricitinib
Baricitinib (JAN/USAN/INN)
Olumiant (TN)
OTHER BARICITINIB
[2]
JAK1
JAK1
,
JAK2
💬
5.
Baricitinib
treatment
×
Name
Full Name
JAK1
Janus kinase 1
JAK2
Janus kinase 2
[35]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
[35]
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
[1]
46
46
💬
5.
Baricitinib
treatment
×
Disease ID
Name
46
Malignant rheumatoid arthritis
6
Baricitinib
, olumiant®
[1]
Baricitinib
Baricitinib
(
Baricitinib
)
[1]
Baricitinib
Baricitinib
(
Baricitinib
, OTHER
BARICITINIB
)
💬
6.
Baricitinib
, olumiant®
×
Name
Other Names
Baricitinib
Baricitinib (JAN/USAN/INN)
Olumiant (TN)
OTHER BARICITINIB
[2]
JAK1
JAK1
,
JAK2
💬
6.
Baricitinib
, olumiant®
×
Name
Full Name
JAK1
Janus kinase 1
JAK2
Janus kinase 2
[35]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
[35]
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
[1]
46
46
💬
6.
Baricitinib
, olumiant®
×
Disease ID
Name
46
Malignant rheumatoid arthritis
7
Tofacitinib or
Baricitinib
[2]
Baricitinib
Baricitinib
(
Baricitinib
),
Tofacitinib
[2]
Tofacitinib
Tofacitinib
,
Baricitinib
(
Baricitinib
, OTHER
BARICITINIB
)
💬
7. Tofacitinib or
Baricitinib
×
Name
Other Names
Tofacitinib
Tofacitinib (USAN)
Tasocitinib
Baricitinib
Baricitinib (JAN/USAN/INN)
Olumiant (TN)
OTHER BARICITINIB
[4]
JAK1
JAK1
,
JAK2
,
JAK3
,
TYK2
💬
7. Tofacitinib or
Baricitinib
×
Name
Full Name
JAK1
Janus kinase 1
JAK2
Janus kinase 2
JAK3
Janus kinase 3
TYK2
tyrosine kinase 2
[37]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-small cell lung cancer
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Primary immunodeficiency
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
[37]
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
[1]
46
46
💬
7. Tofacitinib or
Baricitinib
×
Disease ID
Name
46
Malignant rheumatoid arthritis
8
Tofacitinib/
baricitinib
[2]
Baricitinib
Baricitinib
(
Baricitinib
),
Tofacitinib
[2]
Tofacitinib
Tofacitinib
,
Baricitinib
(
Baricitinib
, OTHER
BARICITINIB
)
💬
8. Tofacitinib/
baricitinib
×
Name
Other Names
Tofacitinib
Tofacitinib (USAN)
Tasocitinib
Baricitinib
Baricitinib (JAN/USAN/INN)
Olumiant (TN)
OTHER BARICITINIB
[4]
JAK1
JAK1
,
JAK2
,
JAK3
,
TYK2
💬
8. Tofacitinib/
baricitinib
×
Name
Full Name
JAK1
Janus kinase 1
JAK2
Janus kinase 2
JAK3
Janus kinase 3
TYK2
tyrosine kinase 2
[37]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-small cell lung cancer
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Primary immunodeficiency
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
[37]
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
[1]
46
46
💬
8. Tofacitinib/
baricitinib
×
Disease ID
Name
46
Malignant rheumatoid arthritis